Latest News
The American Health Assistance Foundation today announced a significant discovery in Alzheimer's disease research by one of its grantees, Paul Lombroso, whose efforts resulted in discovery of a new therapeutic drug target that may help protect against the loss of cognition seen in Alzheimer's disease patients.
A team of researchers, led by Lee Goldstein at Boston University School of Medicine and the Boston University Alzheimer's Disease Center, announced today findings that could lead to an eye test for early detection of Alzheimer's disease, a discovery in part made possible through a grant from the American Health Assistance Foundation.
The American Health Assistance Foundation has awarded 52 grants totaling more than $8 million dollars to scientists worldwide who are on the cutting edge of promising discoveries in the areas of Alzheimer's disease, macular degeneration and glaucoma.
After an extensive nationwide executive search, the Board of Directors of the American Health Assistance Foundation (AHAF) announced today the appointment of Stacy Pagos Haller as its new President and Chief Executive Officer.
In recognition of November being National Alzheimer's Disease Awareness Month, the American Health Assistance Foundation has prepared a newsletter highlighting exciting research in the area of Alzheimer's disease
To date, the American Health Assistance Foundation (AHAF) has awarded 391 research grants totaling $65,947,734 to search for treatments and a cure for Alzheimer's disease. Projections estimate that 106 million people worldwide and their families will be suffering the devastation of this life-robbing disease by the year 2050.
The American Health Assistance Foundation (AHAF) and the Asbury Methodist Village are partnering to host a special community screening and discussion of the HBO Series, The Alzheimer’s Project to bring awareness to the community about this devastating disease and to share caregiving tips and information on cutting edge research.
The National Institutes of Health (NIH) made available today, through the launch of their new computerized reporting system, the actual amounts spent on research of 215 of their disease categories showing less money was spent on Alzheimer's disease research than originally thought. This information further highlights the importance of private donations to fund research into finding a cure for this devastating illness.
An independent team of scientists is leading Alzheimer's disease research in a new, promising direction. Through a $1 million grant they received last year from Alzheimer's Disease Research, a program of the American Health Assistance Foundation (AHAF), Donald F. Weaver, M.D., Ph.D. and his colleagues at Dalhousie University in Halifax, Nova Scotia, Canada are leading a multi-site, multidisciplinary international effort to design a drug that might one day prevent the onset of this devastating disease.
This year, Alzheimer's Disease Research (ADR), a program of the American Health Assistance Foundation, has awarded $5.2 million in Alzheimer's disease research grants. After reviewing applications from around the world, the ADR Scientific Review Committee awarded 27 grants of two- and three-year duration to scientists from the U.S. and Europe conducting research on Alzheimer's disease.